CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO
Heroin and Fentanyl Use Increasing, Report Suggests
Deaths due to combined heroin and fentanyl use are increasing in the United States, according to a report released on January 27, 2015, by NMS Labs. The report focuses on the number of postmortem cases that tested positive for both heroin and the synthetic analgesic fentanyl (Report Shows an Increase in Heroin and Fentanyl Use). 
In 2014, the number of positive heroin and fentanyl postmortem samples spiked, the report shows. For example, in Q4 of 2014 a lab had found 90 positive postmortem samples of heroin and fentanyl, up %8900 from the same time in 2013 (one positive postmortem sample of heroin and fentanyl). The report also includes a geographic map that displays the distribution of heroin and fentanyl poisoning across the U.S. The map shows a high concentration of positive test results in the North Western U.S as well as in the states Virginia, Kentucky, and West Virginia.
After discovering the trend in early 2014, fentanyl detection was added to all the lab's postmortem panels. In just 90 days the lab saw 88 positive cases for both fentanyl and 6-acetylmorphine (6-MAM), a heroin metabolite, from across the U.S.
Cerilliant provides an extensive selection of Certified Spiking Solutions® for synthetic analgesics and opiates including metabolites, parent drugs, and degradants as well as their stable-labeled internal standards. These certified solutions are suitable for a wide range of GC/MS or LC/MS applications from clinical toxicology, forensic analysis, and urine drug testing to calibrator preparation and isotope dilution methods. Since opiates and synthetic analgesics are classified as controlled substances, we supply most of these reference standards as DEA-exempt solutions for added convenience. 
Cerilliant reference standards are manufactured and certified to the highest industry standards including ISO Guide 34, ISO/IEC 17025, and ISO 13485. Each Certified Spiking Solution® is supported by a comprehensive Certificate of Analysis (COA) which provides all analytical data and uncertainty and traceability information to support regulatory requirements. Click on the link below to view our complete listing of opiate and synthetic analgesic certified reference standards:

Return to Article List

© 2022 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact